Bone Biologics Corp. (BBLG) vs Iterum Therapeutics PLC (ITRMF)
Bone Biologics Corp. and Iterum Therapeutics PLC are both Biotechnology companies. Iterum Therapeutics PLC is the larger, with a market value of $1.6M against $1.4M — 1.2× the size. Bone Biologics Corp. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 12 metrics below, Bone Biologics Corp. leads on 7 and Iterum Therapeutics PLC on 5.
Valuation
Profitability
| Metric | BBLG | ITRMF | Biotechnology median |
|---|---|---|---|
| Gross margin | — | (81.85%) | 65.16% |
| Operating margin | 0.00% | (2,243.48%) | 0.00% |
| Net margin | 0.00% | (2,930.54%) | 0.00% |
| Free cash flow margin | 0.00% | (2,122.61%) | 0.00% |
| Return on equity | (54.96%) | 285.48% | (57.72%) |
| Return on assets | (50.55%) | (111.35%) | (49.22%) |
| Return on invested capital | 0.00% | (455.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack